Antibodies to watch in 2024-Reference-Cited by-同舟云学术

Antibodies to watch in 2024

Published:2024-01-05 Issue:1 Volume:16 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Crescioli Silvia¹^ORCID,Kaplon Hélène²^ORCID,Chenoweth Alicia³^ORCID,Wang Lin⁴^ORCID,Visweswaraiah Jyothsna⁵^ORCID,Reichert Janice M.¹^ORCID

Affiliation:

1. Business Intelligence Research, The Antibody Society, Inc., Framingham, MA, US

2. Translational Medicine Department, Institut de Recherches Internationales Servier, Gif-sur-Yvette, France

3. St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, London, UK

4. Regeneron, Formulation Development, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US

5. Drug Creation, Seismic Therapeutic, Cambridge, MA, US

Funder

funding

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2023.2297450

Reference144 articles.

1. Antibodies to watch in 2019

2. Thomas D Chancellor D Micklus A LaFever S Hay M Chaudhuri S Bowden R Low AW. Clinical development success rates and contributing factors 2011–2020. Biotechnology Innovation Organization Report; 2021 Feb. [accessed 2023 Sept 12]. https://www.bio.org/clinical-development-success-rates-and-contributing-factors-2011-2020.

3. Thomas D Burns J Audette J Carroll A Dow-Hygelund C Hay M Clinical development success rates 2006-2015. Biotechnology Innovation Organization Report; 2016. [accessed 2023 Sept]. https://www.bio.org/sites/default/files/legacy/bioorg/docs/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO %20Biomedtracker %20Amplion%202016.pdf.

4. Lecanemab: First Approval

5. Eisai. FDA grants traditional approval for LEQEMBI® (lecanemab-irmb) for the treatment of Alzheimer’s disease; July 7 2023 press release. [accessed 2023 Aug 15]. https://www.eisai.com/news/2023/news202349.html.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. YabXnization platform: A monoclonal antibody heterologization server based on rational design and artificial intelligence-assisted computation;Computational and Structural Biotechnology Journal;2024-12

2. Advanced applications of Nanodiscs-based platforms for antibodies discovery;Biophysical Chemistry;2024-10

3. Histone post-translational modification and heterochromatin alterations in neurodegeneration: revealing novel disease pathways and potential therapeutics;Frontiers in Molecular Neuroscience;2024-09-13

4. Molecular mechanisms of avian immunoglobulin gene diversification and prospect for industrial applications;Frontiers in Immunology;2024-09-13

5. A new strategy in bioreactor scale-up and process transfer using a dynamic initial vvm according to different aeration pore size;Frontiers in Bioengineering and Biotechnology;2024-09-10